×
About 78,609 results

ALLMedicine™ Gastric Cancer Center

Research & Reviews  38,667 results

Livedoid cutaneous metastasis of signet-ring cell gastric carcinoma.
https://doi.org/10.1111/cup.13969
Journal of Cutaneous Pathology; DemircioĞlu D, Öztürk Durmaz E et. al.

Jan 21st, 2021 - Cutaneous metastasis of gastric cancer is extremely rare. Nodular forms are more common and inflammatory forms are exceptionally encountered. Herein, we report a case of inflammatory cutaneous metastasis of signet-ring cell gastric cancer (poorly ...

Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2...
https://doi.org/10.5009/gnl20288
Gut and Liver; Jung HK, Kang SJ et. al.

Jan 20th, 2021 - Helicobacter pylori infection is one of the most common infectious diseases worldwide. Although the prevalence of H. pylori is gradually decreasing, approximately half of the world's population still becomes infected with this disease. H. pyl...

Early detection of tumor cells in bone marrow and peripheral blood in a fast‑progressin...
https://doi.org/10.3892/ijo.2021.5171
International Journal of Oncology; Bali P, Lozano-Pope I et. al.

Jan 20th, 2021 - Helicobacter pylori (H. pylori) infection is a major risk factor for the development of gastric cancer. The authors previously demonstrated that in mice deficient in myeloid differentiation primary response 88 (Myd88‑/‑), infection with Helicobact...

Complementary and alternative therapies for precancerous lesions of gastric cancer: A p...
https://doi.org/10.1097/MD.0000000000024249
Medicine Zhang T, Zhang T et. al.

Jan 20th, 2021 - Gastric cancer is one of the most common malignant tumors, which seriously affect peoples quality of life and threaten people's health. Precancerous lesions of gastric cancer (PLGC) are a critical stage in the occurrence and development of gastric...

see more →

Guidelines  83 results

Hereditary diffuse gastric cancer: updated clinical practice guidelines.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116190
The Lancet. Oncology; Blair VR, McLeod M et. al.

Aug 7th, 2020 - Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome that is characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is largely caused by inactivating germline mutations in the tumour...

Enhertu Impresses in HER2-Positive Gastric Cancer
https://www.medpagetoday.com/meetingcoverage/asco/86766

May 28th, 2020 - Pretreated gastric cancer patients with HER2-positive disease had significantly improved rates of response and survival with trastuzumab deruxtecan (Enhertu) rather than chemotherapy, an open-label phase II trial showed.

Hereditary Cancer Syndromes and Risk Assessment ACOG COMMITTEE OPINION, Number 793
https://journals.lww.com/greenjournal/Fulltext/2019/12000/Hereditary_Cancer_Syndromes_and_Risk_Assessment_.39.aspx
Obstetrics & Gynecology; ACOG

Nov 30th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...

Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
https://doi.org/10.1097/AOG.0000000000003562
Obstetrics and Gynecology;

Nov 25th, 2019 - A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheri...

Gastric Cancer Treatment (PDQ®)–Health Professional Version Go to Patient Version
https://www.cancer.gov/types/stomach/hp/stomach-treatment-pdq

Oct 10th, 2019 - Gastric cancer treatment options depend on extent of disease and may include radical surgery, chemotherapy, radiation, and immunotherapy. Get detailed information about the diagnosis, treatment, and prognosis of newly diagnosed and recurrent gastr...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  39,265 results

Livedoid cutaneous metastasis of signet-ring cell gastric carcinoma.
https://doi.org/10.1111/cup.13969
Journal of Cutaneous Pathology; DemircioĞlu D, Öztürk Durmaz E et. al.

Jan 21st, 2021 - Cutaneous metastasis of gastric cancer is extremely rare. Nodular forms are more common and inflammatory forms are exceptionally encountered. Herein, we report a case of inflammatory cutaneous metastasis of signet-ring cell gastric cancer (poorly ...

Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea 2...
https://doi.org/10.5009/gnl20288
Gut and Liver; Jung HK, Kang SJ et. al.

Jan 20th, 2021 - Helicobacter pylori infection is one of the most common infectious diseases worldwide. Although the prevalence of H. pylori is gradually decreasing, approximately half of the world's population still becomes infected with this disease. H. pyl...

Early detection of tumor cells in bone marrow and peripheral blood in a fast‑progressin...
https://doi.org/10.3892/ijo.2021.5171
International Journal of Oncology; Bali P, Lozano-Pope I et. al.

Jan 20th, 2021 - Helicobacter pylori (H. pylori) infection is a major risk factor for the development of gastric cancer. The authors previously demonstrated that in mice deficient in myeloid differentiation primary response 88 (Myd88‑/‑), infection with Helicobact...

Complementary and alternative therapies for precancerous lesions of gastric cancer: A p...
https://doi.org/10.1097/MD.0000000000024249
Medicine Zhang T, Zhang T et. al.

Jan 20th, 2021 - Gastric cancer is one of the most common malignant tumors, which seriously affect peoples quality of life and threaten people's health. Precancerous lesions of gastric cancer (PLGC) are a critical stage in the occurrence and development of gastric...

see more →

News  585 results

Gut Microbiome Predicts Nivolumab Efficacy in Gastric Cancer?
https://www.medscape.com/viewarticle/944261

Jan 17th, 2021 - Preliminary data suggest that a certain pattern of gut microbes may be useful in predicting which patients with advanced gastric cancer are likely to benefit from treatment with the immunotherapy nivolumab (Opdivo). Researchers have demonstrated b...

Better Survival With S-1/Docetaxel in Stage III Gastric Cancer
https://www.medscape.com/viewarticle/944265

Jan 17th, 2021 - A new recommendation for the treatment of patients with gastric cancer has been proposed on the basis of final results from the phase 3 trial GC-07, which showed survival benefit. The trial was conducted by the Japan Clinical Cancer Research Organ...

Uncovered Self-Expandable Stent Likely Preferable for Malignant Gastric Outlet Obstruction
https://www.medscape.com/viewarticle/942099

Dec 7th, 2020 - NEW YORK (Reuters Health) - Covered and uncovered self-expandable metal stents (SEMS) for malignant gastric outlet obstruction show only minor differences, suggests a randomized trial in Japan. U.S. experts agree, noting that covered stents are no...

H Pylori Eradication Testing Less Likely in Black Patients
https://www.medscape.com/viewarticle/940437

Nov 4th, 2020 - Black patients may be significantly less likely to receive eradication testing after treatment for Helicobacter pylori infection than patients of other races/ethnic groups, based on a retrospective analysis of more than 1,700 individuals. This dis...

'Paradigm Shift' in Gastric Junction Cancers With Nivolumab
https://www.medscape.com/viewarticle/937916

Sep 22nd, 2020 - Patients with gastric cancer or gastroesophageal junction cancer (GEJ) could experience significantly improved progression-free survival, and maybe also overall survival, with nivolumab (Opdivo) in the first-line and neoadjuvant settings, suggest ...

see more →

Patient Education  5 results see all →